Bioventus Inc (BVS)
14.16
+0.58
(+4.27%)
USD |
NASDAQ |
Nov 04, 13:04
Bioventus Total Liabilities (Quarterly): 603.11M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 603.11M |
| March 31, 2024 | 576.81M |
| December 31, 2023 | 589.79M |
| September 30, 2023 | 584.65M |
| June 30, 2023 | 603.62M |
| March 31, 2023 | 647.04M |
| December 31, 2022 | 960.43M |
| September 30, 2022 | 1.019B |
| June 30, 2022 | 688.59M |
| Date | Value |
|---|---|
| March 31, 2022 | 675.22M |
| December 31, 2021 | 692.07M |
| September 30, 2021 | 424.29M |
| June 30, 2021 | 427.27M |
| March 31, 2021 | 422.79M |
| December 31, 2020 | 350.31M |
| September 30, 2020 | 333.94M |
| December 31, 2019 | 326.79M |
| March 31, 2016 | 299.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
326.79M
Minimum
Dec 2019
1.019B
Maximum
Sep 2022
583.86M
Average
589.79M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp | 16.50B |
| Insulet Corp | 1.883B |
| Perspective Therapeutics Inc | 44.92M |
| Xtant Medical Holdings Inc | 50.57M |
| Catheter Precision Inc | 11.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 792.17M |
| Shareholders Equity (Quarterly) | 150.94M |
| Debt to Equity Ratio | 2.539 |
| Current Ratio | 1.334 |
| Net Debt Paydown Yield | 3.33% |